Clinical Trial Update: Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update indicates a study evaluating the clinical impact of interrupting versus maintaining aromatase inhibitor therapy in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Grade Endometrial Stromal Sarcoma

Drugs mentioned

• Aromatase inhibitor (Aromatase inhibitor)

Snippet

Sponsor: Centre Leon Berard | Conditions: Low Grade Endometrial Stromal Sarcoma | Phase 2 | Status: RECRUITING